← Back to catalogue

LIAISON XL MUREX Anti-HBe and Control Anti-HBe

FDA PMA

Class II (US FDA PMA)

PMA P180049

by Diasorin Inc.

Identity

Trade Name
LIAISON® XL MUREX anti-HBe, LIAISON® XL MUREX Control anti-HBe FDA PMA
Generic Name
Qualitative and Quantitative Hepatitis B Virus Antibody assays FDA PMA

Identifiers

PMA Number
P180049 FDA PMA
FDA Product Code
SEI FDA PMA

Classification

Device Class
Class II FDA PMA
Legislation / Framework
21 CFR Part 866.3173 FDA PMA
Regulation Number
866.3173 FDA PMA
Advisory Committee
Microbiology FDA PMA
FDA Decision
APRL FDA PMA

The LIAISON XL MUREX Anti-HBe and Control Anti-HBe are in vitro chemiluminescent immunoassays (CLIA) for the qualitative detection of total antibodies to hepatitis B e antigen (anti-HBe) in human serum and plasma (lithium heparin, sodium citrate, and K2 EDTA), including separator tubes. The assay is designed for use on the LIAISON XL Analyzer and supports diagnostic evaluation of hepatitis B virus (HBV) infection in adult and pediatric patients aged 2 to 21 years. The Control Anti-HBe serves as a quality control sample to monitor assay performance, ensuring reliability of results.

The LIAISON XL MUREX Anti-HBe and Control Anti-HBe are intended for laboratory use only and are not approved for screening blood, plasma, or tissue donors. Supplied as single-use reagents, they require storage and handling according to manufacturer guidelines. The device is authorized under an FDA Premarket Approval (PMA) and classified under device class II (866.3173). Performance characteristics are established exclusively for the LIAISON XL Analyzer platform.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Diasorin Inc.
FDA Applicant
DiaSorin, Inc.

Sources (1)

  • FDA PMA P180049 24 fields · synced Oct 6, 2026